Corrigendum to Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2016 to 31 March 2016 (Official Journal of the European Union C 154 of 29 April 2016) 2016/C 312/03
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/corrigendum/oj/C/2016/312/03@2016-03-01/en
On page 6: for: Date of the decision Name of the medicinal product Holder of the marketing authorisation Number of the entry in the Community Register Date of notification 23.3.2016 Zydelig Gilead Sciences International Limited Cambridge CB21 6GT, United Kingdom EU/1/14/938 30.3.2016 read: Date of the decision Name of the medicinal product Holder of the marketing authorisation Number of the entry in the Community Register Date of notification 23.3.2016 Zydelig Gilead Sciences International Limited Cambridge CB21 6GT, United Kingdom EU/1/14/938 30.3.2016
corr_1 —
Suspension of a marketing authorisation (Article 20 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)
Modification of a marketing authorisation (Article 20 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)